A successful Australian Register of Therapeutic Goods (ARTG) listing hinges on a high-quality submission. Avoidable errors in TGA applications often lead to delays or rejection. By following regulatory best practices and ensuring precision, manufacturers can significantly reduce assessment time and accelerate market access.
Technical Documentation Deficiencies
The most frequent cause of an unsuccessful application is missing or inadequate technical data required to satisfy the Essential Principles. This includes clinical evidence gaps, such as insufficient data or failing to critically assess the evidence presented.
Delays also occur when required manufacturing information (like TGA-issued GMP clearance or licences) is missing or has expired for all steps involved.
Classification and Scope Errors
Incorrectly defining your device’s regulatory standing is another mistake that results in ineffective TGA approval in Australia. Misclassification leads to providing inappropriate evidence and causes significant delays.
An unclear intended purpose also halts the process, as the TGA must have an unambiguous understanding of the device’s function.
Administrative Mistakes in TGA Applications
Simple administrative mistakes frequently halt the formal acceptance of TGA applications. These include incomplete forms, such as missing required ARTG numbers, or poor proofreading and formatting, where the submission fails to adhere strictly to TGA guidelines, deeming the entire dossier ineffective.
Achieving a Right-First-Time Submission
Don’t let avoidable mistakes derail your launch timeline. Is your technical file robust, your device classification accurate, and your dossier prepared by an expert in the complexities of the TGA applications framework? Minimise your risk with informed preparation by partnering with an expert, such as a seasoned medical device consultant in Australia.